EXPERT OPINION ON EMERGING DRUGS
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
EXPERT OPINION ON EMERGING DRUGS
EXPERT OPIN EMERG DR
ISSN / eISSN
1472-8214 / 1744-7623
Aims and Scope
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
Subject Area
PHARMACOLOGY & PHARMACY
CiteScore
5.20
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pharmacology (medical) | Q2 | #91/260 |
| Medicine - Pharmacology | Q2 | #137/301 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| PHARMACOLOGY & PHARMACY - SCIE | Q2 |
H-index
43
Country/Area of Publication
ENGLAND
Publisher
Taylor and Francis Ltd.
Publication Frequency
Quarterly
Year Publication Started
2001
Annual Article Volume
31
Open Access
NO
Contact
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started